Hang Hock Shim

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Perceptions of non-alcoholic fatty liver disease – an Asian community-based study

George Boon‐Bee Goh, Clarence Kwan, Sze Ying Lim et al. · Gastroenterology report · 2015 · 50 citations · Full text

Medicine, Community Health, Epidemiology +12

Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability

Webber Chan, Hang Hock Shim, Miao Shan Lim et al. · Digestive and Liver Disease · 2017 · 50 citations

Social Sciences, Psychiatry, Psychology +12

Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn’s Disease: A Canadian Multi-Centre Observational Cohort Study

Hang Hock Shim, Christopher Ma, Paulo Gustavo Kotze et al. · Journal of the Canadian Association of Gastroenterology · 2018 · 49 citations · Full text

Medicine, Clinical Sciences, Surgery +17

Predictive Role of <i>NUDT15</i> Variants on Thiopurine-Induced Myelotoxicity in Asian Inflammatory Bowel Disease Patients

Natalia Sutiman, Sylvia Chen, Khoon Lin Ling et al. · Pharmacogenomics · 2017 · 39 citations · Full text

Medicine, Hematology, Pharmacology +15